<?xml version="1.0" encoding="UTF-8" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<atom:link href="https://www.manufacturingchemist.com/rss" rel="self" type="application/rss+xml" />
 <title>Manufacturing Chemist</title>
 <description>Manufacturing Chemist serves the pharmaceutical and biopharmaceutical sectors. It offers comprehensive coverage of the industry, including drug discovery, development, manufacturing, packaging and regulatory issues. The magazine serves as a single source of information and reference for pharmaceutical researchers, scientists and decision-makers worldwide</description>
 <link>https://www.manufacturingchemist.com/</link>
 <copyright>Copyright: (C) HPCi Media Limited, https://www.hpcimedia.com/tsandcs</copyright>
 <lastBuildDate>Mon, 20 Apr 2026 10:32:01 +0000</lastBuildDate>
 <ttl>1800</ttl> <item>
  <title>Freudenberg Medical launches CleanAssure ISO Class 5 cleanroom service for sterile single-use biopharma assemblies</title>
  <description>CleanAssure is an ISO Class 5 controlled cleanroom service delivering washed, dried and gamma-sterilised single-use assemblies to biopharmaceutical customers, addressing industry challenges around cleaning validation and contamination risk</description>
  <link>https://www.manufacturingchemist.com/freudenberg-medical-cleanassure-iso-class-5-cleanroom-sterile-biopharma</link>
  <guid isPermaLink="false">https://www.manufacturingchemist.com/freudenberg-medical-cleanassure-iso-class-5-cleanroom-sterile-biopharma</guid>
  <pubDate>Mon, 20 Apr 2026 10:20:00 +0000</pubDate>
 </item> <item>
  <title>New leadership at DWK Life Sciences: Michael Werth succeeds Armin Reiche</title>
  <description>After serving as CEO for 25 years, Armin Reiche hands operational responsibility to Michael Werth and joins the Advisory Board</description>
  <link>https://www.manufacturingchemist.com/new-leadership-at-dwk-life-sciences-michael-werth</link>
  <guid isPermaLink="false">https://www.manufacturingchemist.com/new-leadership-at-dwk-life-sciences-michael-werth</guid>
  <pubDate>Mon, 20 Apr 2026 09:46:00 +0000</pubDate>
 </item> <item>
  <title>Ion chromatography in pharmaceutical analysis: a long road to acceptance</title>
  <description>John Welch, Associate Director, Butterworth Laboratories, writes on how ion chromatography evolved into a mature and widely adopted pharmaceutical analysis technique</description>
  <link>https://www.manufacturingchemist.com/ion-chromatography-in-pharmaceutical-analysis-a-long-road</link>
  <guid isPermaLink="false">https://www.manufacturingchemist.com/ion-chromatography-in-pharmaceutical-analysis-a-long-road</guid>
  <pubDate>Sun, 19 Apr 2026 23:00:00 +0000</pubDate>
 </item> <item>
  <title>Step into Cognitive Manufacturing: Step into IMA Digital Ecosystem</title>
  <description>At Interpack 2026, IMA invites you on a journey through an entire pavilion transformed into a living, breathing expression of what the Group calls Cognitive Manufacturing</description>
  <link>https://www.manufacturingchemist.com/step-into-cognitive-manufacturing-step-into-ima-digital</link>
  <guid isPermaLink="false">https://www.manufacturingchemist.com/step-into-cognitive-manufacturing-step-into-ima-digital</guid>
  <pubDate>Fri, 17 Apr 2026 15:40:00 +0000</pubDate>
 </item> <item>
  <title>Mabwell signs Malaysia licensing deal for denosumab biosimilars MAILISHU and MAIWEIJIAN</title>
  <description>Mabwell has entered a licensing and commercialisation agreement to bring its denosumab biosimilars to Malaysia, supporting regional access through local registration and supply of its Prolia and Xgeva reference products</description>
  <link>https://www.manufacturingchemist.com/mabwell-signs-malaysia-licensing-deal-for-denosumab-biosimilars</link>
  <guid isPermaLink="false">https://www.manufacturingchemist.com/mabwell-signs-malaysia-licensing-deal-for-denosumab-biosimilars</guid>
  <pubDate>Fri, 17 Apr 2026 15:25:00 +0000</pubDate>
 </item> <item>
  <title>Roche launches global Phase III Elevidys trial to support EU approval for Duchenne gene therapy</title>
  <description>Roche has initiated a new Phase III study of Elevidys, aiming to generate placebo-controlled data for European Medicines Agency resubmission and expand access to the Duchenne muscular dystrophy gene therapy</description>
  <link>https://www.manufacturingchemist.com/roche-phase-iii-elevidys-trial-eu-approval-duchenne</link>
  <guid isPermaLink="false">https://www.manufacturingchemist.com/roche-phase-iii-elevidys-trial-eu-approval-duchenne</guid>
  <pubDate>Fri, 17 Apr 2026 11:22:00 +0000</pubDate>
 </item> <item>
  <title>OpenAI launches GPT-Rosalind to accelerate life sciences research and drug discovery workflows</title>
  <description>The new AI model designed for biochemistry, genomics and pharmaceutical R&amp;D aims to speed early-stage discovery while maintaining security and governance in regulated environments</description>
  <link>https://www.manufacturingchemist.com/openai-launches-gpt-rosalind-to-accelerate-life-sciences</link>
  <guid isPermaLink="false">https://www.manufacturingchemist.com/openai-launches-gpt-rosalind-to-accelerate-life-sciences</guid>
  <pubDate>Fri, 17 Apr 2026 10:30:00 +0000</pubDate>
 </item> <item>
  <title>Implementing compendial methods to minimise testing risk</title>
  <description>Understanding feasibility testing and verification to ensure reliable analytical results</description>
  <link>https://www.manufacturingchemist.com/implementing-compendial-methods-to-minimise-testing-risk</link>
  <guid isPermaLink="false">https://www.manufacturingchemist.com/implementing-compendial-methods-to-minimise-testing-risk</guid>
  <pubDate>Thu, 16 Apr 2026 23:00:00 +0000</pubDate>
 </item> <item>
  <title>&quot;Miracle&quot; Alzheimer&#039;s drugs show no meaningful benefit, says major review</title>
  <description>Amyloid-clearing drugs hailed as a breakthrough for Alzheimer&#039;s treatment make &quot;no meaningful difference to patients&quot; and increase the risk of brain swelling and bleeding, according to a sweeping new Cochrane meta-analysis</description>
  <link>https://www.manufacturingchemist.com/miracle-alzheimer-drugs-show-no-meaningful-benefit-says-review</link>
  <guid isPermaLink="false">https://www.manufacturingchemist.com/miracle-alzheimer-drugs-show-no-meaningful-benefit-says-review</guid>
  <pubDate>Thu, 16 Apr 2026 14:58:00 +0000</pubDate>
 </item> <item>
  <title>Engineering for change: PFAS regulations and what they mean for Titan&#039;s flowmeters</title>
  <description>With regulatory scrutiny of ‘forever chemicals’ intensifying globally, particularly within the EU, strict regulations ahead are expected regarding materials containing fluorinated substances</description>
  <link>https://www.manufacturingchemist.com/engineering-for-change-pfas-regulations-and-what-they</link>
  <guid isPermaLink="false">https://www.manufacturingchemist.com/engineering-for-change-pfas-regulations-and-what-they</guid>
  <pubDate>Thu, 16 Apr 2026 13:38:00 +0000</pubDate>
 </item> <item>
  <title>MasterControl appoints David Edwards as CEO to drive next phase of growth</title>
  <description>Former CEO Jon Beckstrand Appointed Chairman of the Board; Prior Chair and Salt Lake City Business Pioneer Richard Beckstrand Transitions to Board Member</description>
  <link>https://www.manufacturingchemist.com/mastercontrol-appoints-david-edwards-as-ceo-to-drive</link>
  <guid isPermaLink="false">https://www.manufacturingchemist.com/mastercontrol-appoints-david-edwards-as-ceo-to-drive</guid>
  <pubDate>Thu, 16 Apr 2026 13:32:00 +0000</pubDate>
 </item> <item>
  <title>Pangea Pharmaceuticals launches FDA-approved amlodipine oral solution Sdamlo</title>
  <description>Pangea’s Sdamlo, the first FDA-approved amlodipine powder for oral solution, leverages a patent-pending lyophilisation process to enable precise unit-dose delivery and improved administration for paediatric, geriatric and dysphagic patients</description>
  <link>https://www.manufacturingchemist.com/pangea-pharmaceuticals-fda-approved-amlodipine-oral-solution-sdamlo</link>
  <guid isPermaLink="false">https://www.manufacturingchemist.com/pangea-pharmaceuticals-fda-approved-amlodipine-oral-solution-sdamlo</guid>
  <pubDate>Thu, 16 Apr 2026 10:32:00 +0000</pubDate>
 </item> <item>
  <title>Ardena opens new bioanalytical lab in New Jersey to boost North American operations</title>
  <description>The CDMO has started operations at its new facility in Somerset, New Jersey, bringing its bioanalytical services closer to biopharma clients&#039; development programmes to support preclinical and clinical studies</description>
  <link>https://www.manufacturingchemist.com/ardena-opens-new-bioanalytical-lab-new-jersey-american</link>
  <guid isPermaLink="false">https://www.manufacturingchemist.com/ardena-opens-new-bioanalytical-lab-new-jersey-american</guid>
  <pubDate>Thu, 16 Apr 2026 10:01:00 +0000</pubDate>
 </item> <item>
  <title>See. Try. Believe. Experience the Lyza 7000 FTIR with a 70-day risk free trial</title>
  <description>Laboratories can now evaluate the Lyza 7000 FTIR spectrometer in their own environment through a new 70-day, no-cost, no-risk trial program. The initiative allows teams to run real samples, follow existing SOPs, and fully explore the instrument’s capabilities before making a purchase decision</description>
  <link>https://www.manufacturingchemist.com/see-try-believe-experience-the-lyza-7000-ftir</link>
  <guid isPermaLink="false">https://www.manufacturingchemist.com/see-try-believe-experience-the-lyza-7000-ftir</guid>
  <pubDate>Thu, 16 Apr 2026 08:25:00 +0000</pubDate>
 </item> <item>
  <title>From crisis response to operational resilience: rethinking recovery in pharmaceutical manufacturing (part II)</title>
  <description>Building on Part I, effective investigations integrate strategy, observation, risk, data and sustainability to address root causes and enable resilient recovery</description>
  <link>https://www.manufacturingchemist.com/from-crisis-response-to-operational-resilience-rethinking-recovery-1</link>
  <guid isPermaLink="false">https://www.manufacturingchemist.com/from-crisis-response-to-operational-resilience-rethinking-recovery-1</guid>
  <pubDate>Thu, 16 Apr 2026 07:00:00 +0000</pubDate>
 </item> <item>
  <title>Amazon rolls out AI-powered platform Amazon Bio Discovery for drug discovery</title>
  <description>The new application will assist with drug design, allowing more researchers to access leading AI models rather than just those with AI and coding skills. Already in use with partners such as MSK, the platform has reduced the timeline for antibody design for potential pediatric cancer therapies from months to weeks</description>
  <link>https://www.manufacturingchemist.com/amazon-ai-powered-platform-amazon-bio-discovery-drug</link>
  <guid isPermaLink="false">https://www.manufacturingchemist.com/amazon-ai-powered-platform-amazon-bio-discovery-drug</guid>
  <pubDate>Wed, 15 Apr 2026 11:27:00 +0000</pubDate>
 </item> <item>
  <title>GSK completes acquisition of 35Pharma, gaining pulmonary hypertension candidate</title>
  <description>The company has completed its purchase of the Canada-based biopharma for $950m, handing it a drug that is a potentially “best-in-class” therapy for blood pressure diseases such as pulmonary arterial hypertension</description>
  <link>https://www.manufacturingchemist.com/gsk-completes-acquisition-of-35pharma-gaining-pulmonary-hypertension</link>
  <guid isPermaLink="false">https://www.manufacturingchemist.com/gsk-completes-acquisition-of-35pharma-gaining-pulmonary-hypertension</guid>
  <pubDate>Wed, 15 Apr 2026 10:57:00 +0000</pubDate>
 </item> <item>
  <title>FairJourney Bio opens US cryo-EM facility to accelerate antibody discovery</title>
  <description>CRO FairJourney Bio has opened its advanced cryo-electron microscopy facility in San Diego, integrating atomic-resolution structural biology into its antibody discovery platform to speed up early-stage drug development</description>
  <link>https://www.manufacturingchemist.com/fairjourney-bio-opens-us-cryo-em-facility-to</link>
  <guid isPermaLink="false">https://www.manufacturingchemist.com/fairjourney-bio-opens-us-cryo-em-facility-to</guid>
  <pubDate>Wed, 15 Apr 2026 10:26:00 +0000</pubDate>
 </item> <item>
  <title>Novo Nordisk and OpenAI partner to accelerate drug discovery with AI integration</title>
  <description>The Wegovy and Ozempic maker has struck a strategic deal with OpenAI to embed artificial intelligence across its entire operations, with full integration targeted by the end of 2026</description>
  <link>https://www.manufacturingchemist.com/novo-nordisk-openai-partner-accelerate-drug-discovery-ai</link>
  <guid isPermaLink="false">https://www.manufacturingchemist.com/novo-nordisk-openai-partner-accelerate-drug-discovery-ai</guid>
  <pubDate>Tue, 14 Apr 2026 14:03:00 +0000</pubDate>
 </item> <item>
  <title>Aragen launches ChemiSHE, India&#039;s first women-led chemistry synthesis laboratory</title>
  <description>The firm has inaugurated ChemiSHE, a pioneering all-women chemistry synthesis laboratory at its Hyderabad campus, as part of a broader diversity initiative targeting the addition of up to 1000 women employees across scientific and leadership roles during the next three years</description>
  <link>https://www.manufacturingchemist.com/aragen-chemishe-india-women-led-chemistry-laboratory</link>
  <guid isPermaLink="false">https://www.manufacturingchemist.com/aragen-chemishe-india-women-led-chemistry-laboratory</guid>
  <pubDate>Tue, 14 Apr 2026 11:48:00 +0000</pubDate>
 </item></channel></rss>